76 related articles for article (PubMed ID: 141460)
1. Effect of prolactin on plasma DHEA (s) levels.
Vermeulen A; Suy E; Rubens R
J Clin Endocrinol Metab; 1977 Jun; 44(6):1222-5. PubMed ID: 141460
[TBL] [Abstract][Full Text] [Related]
2. Prolactin has a direct effect on adrenal androgen secretion.
Higuchi K; Nawata H; Maki T; Higashizima M; Kato K; Ibayashi H
J Clin Endocrinol Metab; 1984 Oct; 59(4):714-8. PubMed ID: 6090494
[TBL] [Abstract][Full Text] [Related]
3. Ovine prolactin potentiates the action of adrenocorticotropic hormone on the secretion of dehydroepiandrosterone sulfate and dehydroepiandrosterone from cultured bovine adrenal cells.
Higuchi K; Nawata H; Kato K; Ibayashi H
Horm Metab Res; 1985 Sep; 17(9):451-3. PubMed ID: 2995221
[TBL] [Abstract][Full Text] [Related]
4. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
Palatsi R; Reinilä M; Kivinén S
Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
[TBL] [Abstract][Full Text] [Related]
5. Failure of acute changes in prolactin to affect DHEA-S secretion in the human.
Wiebe RH; Handwerger S
J Reprod Med; 1983 Mar; 28(3):206-8. PubMed ID: 6222183
[TBL] [Abstract][Full Text] [Related]
6. Role of opiates in gonadotropins and prolactin secretion. Estrogens effect.
Lo Dico G; Riggio V; Cossu A; Buscarinu G; Stoppelli I
Panminerva Med; 1984; 26(3):157-61. PubMed ID: 6097860
[No Abstract] [Full Text] [Related]
7. Plasma 16 beta-hydroxydehydroepiandrosterone in normal and pathological conditions in man.
Sekihara H; Sennett JA; Liddle GW; McKenna TJ; Yarbro LR
J Clin Endocrinol Metab; 1976 Nov; 43(5):1078-84. PubMed ID: 186475
[TBL] [Abstract][Full Text] [Related]
8. Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.
Samojlik E; Veldhuis JD; Wells SA; Santen RJ
J Clin Invest; 1980 Mar; 65(3):602-12. PubMed ID: 6986409
[TBL] [Abstract][Full Text] [Related]
9. Effects of the antipsychotic drug sulpiride on reproductive hormones in healthy men: relationship with body weight regulation.
Baptista T; Alastre T; Contreras Q; Martinez JL; Araujo de Baptista E; Páez X; Hernández L
Pharmacopsychiatry; 1997 Nov; 30(6):250-5. PubMed ID: 9442547
[TBL] [Abstract][Full Text] [Related]
10. Effects of aging on adrenal function in the human: responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women.
Parker CR; Slayden SM; Azziz R; Crabbe SL; Hines GA; Boots LR; Bae S
J Clin Endocrinol Metab; 2000 Jan; 85(1):48-54. PubMed ID: 10634362
[TBL] [Abstract][Full Text] [Related]
11. Changes in cortisol and DHEA plasma levels after psychotherapy for PTSD.
Olff M; de Vries GJ; Güzelcan Y; Assies J; Gersons BP
Psychoneuroendocrinology; 2007 Jul; 32(6):619-26. PubMed ID: 17570603
[TBL] [Abstract][Full Text] [Related]
12. Effects of dehydroepiandrosterone-sulphate (DHEA-S) administration on puerperal lactation and maternal prolactin and estradiol levels.
Aisaka K; Mori H; Ogawa T; Kigawa T
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1935-42. PubMed ID: 6238998
[TBL] [Abstract][Full Text] [Related]
13. The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects.
Schiebinger RJ; Chrousos GP; Cutler GB; Loriaux DL
J Clin Endocrinol Metab; 1986 Jan; 62(1):202-9. PubMed ID: 2999177
[TBL] [Abstract][Full Text] [Related]
14. The effect of bromocriptine on gonadotropin and steroid secretion in polycystic ovarian disease.
Steingold KA; Lobo RA; Judd HL; Lu JK; Chang RJ
J Clin Endocrinol Metab; 1986 May; 62(5):1048-51. PubMed ID: 2937800
[TBL] [Abstract][Full Text] [Related]
15. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
16. Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans.
Young J; Couzinet B; Nahoul K; Brailly S; Chanson P; Baulieu EE; Schaison G
J Clin Endocrinol Metab; 1997 Aug; 82(8):2578-85. PubMed ID: 9253337
[TBL] [Abstract][Full Text] [Related]
17. Low serum dehydroepiandrosterone sulfate in women with primary Sjögren's syndrome as an isolated sign of impaired HPA axis function.
Valtysdóttir ST; Wide L; Hällgren R
J Rheumatol; 2001 Jun; 28(6):1259-65. PubMed ID: 11409117
[TBL] [Abstract][Full Text] [Related]
18. Ovarian and adrenal contributions to peripheral steroid levels in postmenopausal women.
Maroulis GB; Abraham GE
Obstet Gynecol; 1976 Aug; 48(2):150-4. PubMed ID: 133306
[TBL] [Abstract][Full Text] [Related]
19. Adrenal suppression with aminoglutethimide. III. Comparison of plasma delta 4- and delta 5-steroids in postmenopausal women treated for breast carcinoma.
Samojlik E; Santen RJ
J Clin Endocrinol Metab; 1978 Oct; 47(4):717-24. PubMed ID: 162517
[TBL] [Abstract][Full Text] [Related]
20. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
Labrie F; Bélanger A; Cusan L; Candas B
J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
